InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV – Free Report) saw a significant decrease in short interest in June. As of June 15th, there was short interest totalling 27,500 shares, a decrease of 36.0% from the May 31st total of 43,000 shares. Currently, 1.0% of the shares of the company are sold short. Based on an average […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a research report sent to investors on Saturday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Up 3.1 % NASDAQ:NVIV opened at $1.35 on Friday. The firm has a market cap of $4.20 million, a PE […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a report published on Saturday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance Shares of NASDAQ:NVIV opened at $1.31 on Friday. The stock has a market capitalization of $4.07 million, a price-to-earnings ratio of -0.16 […]
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV – Get Rating) was the target of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 43,000 shares, a decline of 30.9% from the May 15th total of 62,200 shares. Approximately 1.6% of the company’s stock are short sold. […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a report released on Wednesday. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance InVivo Therapeutics stock opened at $1.28 on Wednesday. InVivo Therapeutics has a 1-year low of $0.81 and a 1-year high of $13.77. […]